PATENT CLAIM ANALYSIS

Application Number: 15961394
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "252130"]

Abstract:
The present invention relates to dosing regimen of a new antimalarial drug, as monotherapy or combination therapy.

Claim (Index 4):
The compound according to  claim 1 , wherein the compound is administered daily at a dose of about 800 mg, during 2 to 5 days, e.g. 2 or 3 days.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 91.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15741786', '15532280', '14978059', '12833909', '14332829']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.777423787762711
- 35 USC 102 Novelty (BERT): 0.5191029158249355
- Combined Prediction Score: 0.7515917005689334
- Mean Citation Score: 243.177624
- Max Citation Score: 278.0089
- Similarity Product: 167.16416687116626

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test